Literature DB >> 21499121

Central corneal thickness and intraocular pressure in a Nepalese population: the Bhaktapur Glaucoma Study.

Suman S Thapa1, Indira Paudyal, Shankar Khanal, Nabin Paudel, Steven L Mansberger, Ger H M B van Rens.   

Abstract

PURPOSE: The purpose of the study was to evaluate the characteristics of central corneal thickness and its association with age, sex, and intraocular pressure in a Nepalese population. PATIENTS AND METHODS: The study design was a cross-sectional, population-based survey. Two thousand three hundred thirty patients aged 40 years and older were examined at Tilganga Institute of Ophthalmology, a tertiary referral eye centre in Kathmandu, Nepal. All patients underwent a complete ophthalmic examination that included measurements of central corneal thickness with an ultrasonic pachymeter and intraocular pressure with a Goldman type applanation tonometer.
RESULTS: The main outcome measures were central corneal thickness and intraocular pressure. Mean age of the 2330 patients examined was 51.3 years (SD±9.56). The mean central corneal thickness and mean intraocular pressure was 539.10 μm (SD±33.73) and 13.33 mm Hg (SD±2.26), respectively. Central corneal thickness showed an average decrease of 2.67 μm (95% confidence interval, 2.21-4.1) per decade increase in age. A 100 μm increase in central corneal thickness was associated with a 1.03 mm Hg (95% confidence interval, 0.79-1.26) increase in intraocular pressure after adjusting for age and sex.
CONCLUSIONS: The changes in central corneal thickness values cause a significant variation in intraocular pressure in this population, suggesting that measurement of central corneal thickness will have implications in the diagnosis and management of glaucoma.

Entities:  

Mesh:

Year:  2012        PMID: 21499121     DOI: 10.1097/IJG.0b013e3182182c0f

Source DB:  PubMed          Journal:  J Glaucoma        ISSN: 1057-0829            Impact factor:   2.503


  7 in total

1.  Distribution of intraocular pressure and its determinants in an Iranian adult population.

Authors:  Hassan Hashemi; Mehdi Khabazkhoob; Mohammad Hassan Emamian; Mohammad Shariati; Abbasali Yekta; Akbar Fotouhi
Journal:  Int J Ophthalmol       Date:  2016-08-18       Impact factor: 1.779

2.  Assessment of intraocular pressure measured by Reichert Ocular Response Analyzer, Goldmann Applanation Tonometry, and Dynamic Contour Tonometry in healthy individuals.

Authors:  Ping-Bo Ouyang; Cong-Yi Li; Xiao-Hua Zhu; Xuan-Chu Duan
Journal:  Int J Ophthalmol       Date:  2012-02-18       Impact factor: 1.779

3.  Intra-Ocular Pressure Measurement in a Patient with a Thin, Thick or Abnormal Cornea.

Authors:  Colin I Clement; Douglas G A Parker; Ivan Goldberg
Journal:  Open Ophthalmol J       Date:  2016-02-29

4.  Distribution of IOP measured with an air puff tonometer in a young population.

Authors:  Hassan Hashemi; Mehdi Khabazkhoob; Payam Nabovati; Negareh Yazdani; Hadi Ostadimoghaddam; Ehsan Shiralivand; Akbar Derakhshan; AbbasAli Yekta
Journal:  J Curr Ophthalmol       Date:  2017-04-02

5.  The Association of Central Corneal Thickness with Ocular and General Parameters in a Community Setting: The Yazd Eye Study.

Authors:  Reza Soleimanizad; Mohammad Hosein Nowroozzadeh; Hossein Ziaei; Mohammad Pakravan; Mehdi Yaseri; Marzieh Katibeh
Journal:  J Ophthalmic Vis Res       Date:  2017 Apr-Jun

6.  Development and Evaluation of the Prognostic Nomogram to Predict Refractive Error in Patients With Primary Angle-Closure Glaucoma Who Underwent Cataract Surgery Combined With Goniosynechialysis.

Authors:  Yuancun Li; Chengyao Guo; Chukai Huang; Liu Jing; Yingzi Huang; Ruiqing Zhou; Kunliang Qiu; Mingzhi Zhang
Journal:  Front Med (Lausanne)       Date:  2021-12-15

7.  Intraocular Pressure and Its Relation to Ocular Geometry: Results From the Gutenberg Health Study.

Authors:  Esther M Hoffmann; Fidan Aghayeva; Felix M Wagner; Achim Fiess; Markus Nagler; Thomas Münzel; Philipp S Wild; Manfred E Beutel; Irene Schmidtmann; Karl J Lackner; Norbert Pfeiffer; Alexander K Schuster
Journal:  Invest Ophthalmol Vis Sci       Date:  2022-01-03       Impact factor: 4.799

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.